© 2020 by the authors.Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the neurodegenerative start several years before the appearance of clinical symptoms. In this brief review, we comment on some molecular and cellular markers appearing at different stages of the disease, before or once the clinical symptoms are evident. These markers are present in biological fluids or could be identified by image techniques. The combined use of molecular and cellular markers will be of interest to determine the development of the different phases of the disease.This research has been founded by grants of Plan Estatal, Spain and CIBERNED
The past decade has seen tremendous efforts in biomarker discovery and validation for neurodegenerat...
The diagnosis of neurodegenerative diseases (NDDs) represents an increasing social burden, with the ...
Several neuroimaging biomarkers have been identified to diagnose Alzheimer’s disease (AD) since the ...
Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the ...
Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the ...
Alzheimer’s disease, the most prevalent type of dementia, affects the life of elderly, to such exten...
The neurodegenerative disorder Alzheimer's disease is characterised by the formation of β-amyloid pl...
The complexity of Alzheimer’s disease (AD) and its long prodromal phase poses challenges for early d...
Alzheimer’s disease (AD) is the most common neurodegenerative disease among the elderly, affecting m...
Alzheimer’s disease (AD) is the most common form of dementia in the elderly, and it is characterized...
Cerebrospinal fluid analyses and neuroimaging can identify the underlying pathophysiology at the ear...
Abstract. A blood-based protein biomarker, or set of protein biomarkers, that could predict onset an...
A molecular test for Alzheimer's disease could lead to better treatment and therapies. We found 18 s...
A molecular test for Alzheimer\u27s disease could lead to better treatment and therapies. We found 1...
A molecular test for Alzheimer's disease could lead to better treatment and therapies. We found 18 s...
The past decade has seen tremendous efforts in biomarker discovery and validation for neurodegenerat...
The diagnosis of neurodegenerative diseases (NDDs) represents an increasing social burden, with the ...
Several neuroimaging biomarkers have been identified to diagnose Alzheimer’s disease (AD) since the ...
Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the ...
Mainly obtained from familial Alzheimer’s disease patients’ data, we know that some features of the ...
Alzheimer’s disease, the most prevalent type of dementia, affects the life of elderly, to such exten...
The neurodegenerative disorder Alzheimer's disease is characterised by the formation of β-amyloid pl...
The complexity of Alzheimer’s disease (AD) and its long prodromal phase poses challenges for early d...
Alzheimer’s disease (AD) is the most common neurodegenerative disease among the elderly, affecting m...
Alzheimer’s disease (AD) is the most common form of dementia in the elderly, and it is characterized...
Cerebrospinal fluid analyses and neuroimaging can identify the underlying pathophysiology at the ear...
Abstract. A blood-based protein biomarker, or set of protein biomarkers, that could predict onset an...
A molecular test for Alzheimer's disease could lead to better treatment and therapies. We found 18 s...
A molecular test for Alzheimer\u27s disease could lead to better treatment and therapies. We found 1...
A molecular test for Alzheimer's disease could lead to better treatment and therapies. We found 18 s...
The past decade has seen tremendous efforts in biomarker discovery and validation for neurodegenerat...
The diagnosis of neurodegenerative diseases (NDDs) represents an increasing social burden, with the ...
Several neuroimaging biomarkers have been identified to diagnose Alzheimer’s disease (AD) since the ...